Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE.
May be as effective as full-dose direct oral anticoagulants for extended-duration treatment.
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin.
Pharmacomechanical thrombolysis used with anticoagulation treatment, did not decrease post-thrombotic syndrome risks but increased major bleeding risks in patients with acute proximal DVT.
Fewer VTE events were observed in the betrixaban than enoxaparin arm.
VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.
Venous thromboembolism is associated with a 4.1-fold increased risk of death and a 2.3-fold increased risk of death-censored graft loss among kidney transplant recipients.
Renal and Urology News Articles
- Aggressive Therapy Warranted for Gleason 10 Prostate Cancer
- PET/CT May Improve Imaging of Recurrent Prostate Cancer
- Adding MRI Does Not Boost Prostate Cancer Upgrading Rate
- Both High and Low Uric Acid Levels Tied to Higher Mortality
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)